Sectors
Chapel Hill spin-out G1 Therapeutics lands $33m series B for less toxic oncology treatments.
Carnegie Mellon University spin-out Dato, formerly GraphLab, raises $18.5m.
Queensland life sciences spin-out Protagonist Therapeutics closes second tranche of $18m series B round.
Existing investor Osage joins the $15m series B round of Liquid Light.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
